EFFECTS OF ACUTE INTRAVENOUS CLOMIPRAMINE ON OBSESSIVE-COMPULSIVE SYMPTOMS AND RESPONSE TO CHRONIC TREATMENT

被引:16
作者
MUNDO, E [1 ]
BELLODI, L [1 ]
SMERALDI, E [1 ]
机构
[1] UNIV MILAN,HOSP SAN RAFFAELE,DEPT NEUROPSYCHIAT SCI,I-20127 MILAN,ITALY
关键词
OBSESSIONS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN; CLOMIPRAMINE; CHALLENGE; PHARMACOTHERAPY;
D O I
10.1016/0006-3223(94)00373-B
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of this study was to test the hypothesis that obsessive-compulsive symptoms are temporarily worsened by acute intravenous clomipramine, suggesting that there is a basal hypersensitivity of serotonin (5-HT) receptors in obsessive-compulsive (OC) patients. We also investigated the relationship of the effects of acute (intravenous) and chronic (oral) administration of clomipramine. Twenty-eight OC patients were recruited. The first part of the study included placebo and clomipramine infusions ann monitoring of OC symptoms by 100 mm Visual Analogue self-rated scales (VAS). There was significant worsening of obsessions in the whole sample during clomipramine infusion. The second part included standardized 10-week oral treatments with clomipramine and evaluation of clinical efficacy. Among the 18 patients who completed the second part of the study, oral clomipramine significantly reduced OC symptoms, but OC patients who had become worse after clomipramine infusion showed higher Y-BOCS scores.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 50 条
  • [1] Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
    Karameh, Wael Karameh
    Khani, Munir
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (02)
  • [2] COMPARISON OF CLOMIPRAMINE, ALPRAZOLAM AND PLACEBO IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER
    STEIN, DJ
    HOLLANDER, E
    MULLEN, LS
    DECARIA, CM
    LIEBOWITZ, MR
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1992, 7 (06) : 389 - 395
  • [3] TRAZODONE TREATMENT IN CLOMIPRAMINE-RESISTANT OBSESSIVE-COMPULSIVE DISORDER
    HERMESH, H
    AIZENBERG, D
    MUNITZ, H
    CLINICAL NEUROPHARMACOLOGY, 1990, 13 (04) : 322 - 328
  • [4] Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder
    Mathew, SJ
    Coplan, JD
    Perko, KA
    Goetz, RR
    de la Neuz, M
    Hollander, E
    Liebowitz, MR
    Fallon, BA
    DEPRESSION AND ANXIETY, 2001, 14 (04) : 199 - 208
  • [5] PROLACTIN IN CHILDHOOD OBSESSIVE-COMPULSIVE DISORDER - CLINICAL CORRELATES AND RESPONSE TO CLOMIPRAMINE
    HANNA, GL
    MCCRACKEN, JT
    CANTWELL, DP
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1991, 30 (02) : 173 - 178
  • [6] Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment
    Marcourakis, Tania
    Bernik, Marcio A.
    Lotufo Neto, Francisco
    Shavitt, Roseli Gedanke
    Gorenstein, Clarice
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (01) : 43 - 48
  • [7] Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine
    Preskorn, Sheldon H.
    Rode, Ryan
    JOURNAL OF PSYCHIATRIC PRACTICE, 2023, 29 (06) : 469 - 475
  • [8] Treatment of obsessive-compulsive disorder using clomipramine in a very old patient
    Trappler, B
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (06) : 686 - 690
  • [9] Intravenous clomipramine challenge in obsessive-compulsive disorder: Predicting response to oral therapy at eight weeks
    Sallee, FR
    Koran, LM
    Pallanti, S
    Carson, SW
    Sethuraman, G
    BIOLOGICAL PSYCHIATRY, 1998, 44 (03) : 220 - 227
  • [10] Obsessive-Compulsive Symptoms in Schizophrenia and in Obsessive-Compulsive Disorder: Differences and Similarities
    Tonna, Matteo
    Ottoni, Rebecca
    Paglia, Francesca
    Monici, Alberto
    Ossola, Paolo
    De Panfilis, Chiara
    Marchesi, Carlo
    JOURNAL OF PSYCHIATRIC PRACTICE, 2016, 22 (02) : 111 - 116